Nadugala, Mahesha N.
Jeewandara, Chandima
Jadi, Ramesh S.
Malavige, Gathsaurie N.
de Silva, Aravinda M.
Premaratne, Prasad H.
Goonasekara, Charitha L.
Funding for this research was provided by:
National Science Foundation of Sri Lanka (RG/2014/BT/03, RG/2014/BT/03, RG/2014/BT/03)
Article History
Received: 15 April 2021
Accepted: 29 September 2021
First Online: 3 November 2021
Declarations
:
: The approval for protocols on recruiting volunteers and collection of blood samples, was obtained by the Institutional Ethical Review Boards of University of Sri Jayewardenepura (595/11) and General Sir John Kotelawela Defence Universities (RP/2014/01). In addition, informed written consent was obtained from all the adult subjects, and the parents/guardians of the child participants, prior to the collection of blood. The Ethical Review Committee of Faculty of Medicine, General Sir John Kotelawala Defence University reviewed and approved the protocols on animal studies (RP/2014/01), which adhered to the guidelines by International Council of Laboratory Animal Science (ICLAS).
: Not applicable.
: The authors declare that they have no competing interests.
: Intellectual properties protected by two national patents; Patent No: 19832—An epitope-based vaccine target with viral neutralization potential for dengue disease. Patent No: 19833—A diagnostic marker for specific identification of the dengue viruses.